Refining breast cancer classification by multiplexed imaging

Refining breast cancer classification by multiplexed imaging
The method enables scientists to simultaneously visualize and analyze multiple biomarkers to generate information-rich digital images. Credit: Bernd Bodenmiller / UZH

An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail. It uses 35 biomarkers to identify the different cell types in breast tumors and its surrounding area compared to the current standard of testing single markers. This increases the precision of tumor analysis and classification—and improves personalized diagnostics for breast cancer patients.

Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This heterogeneity makes it challenging to ascertain the severity of a tumor and assess its molecular subtype, thereby affecting the precision of diagnosis and the choice of the most effective treatment approach. More detailed characterization of a cancer tissue could help improve a treatment's chances of success and may decrease the risk of relapse.

High-dimension biomarkers reveal differences in breast cancer survival

The research group headed by Bernd Bodenmiller, professor of quantitative biology at UZH, has been able to refine the pathological classification of breast cancer using imaging mass cytometry. This method enables scientists to simultaneously visualize and analyze multiple biomarkers to generate information-rich digital images of tissue sections. In their study, the researchers quantified 35 protein biomarkers in . "This created an unprecedented view of a tumor's cellular landscape and the surrounding tissue, which enabled us to determine whether more complex biomarkers exist for clinical outcome," explains Jana Fischer, co-first author of the study.

The team of researchers analyzed hundreds of sections from 350 breast cancer patients and categorized the many cell components and how they are organized in cellular communities and form tumor tissues. "Four categories of breast cancer are routinely classified in the clinic, but our new analysis allows us to go further and identify multiple detailed subcategories of breast cancer. The danger from these diverse tumors can be very different, and each type could respond to therapy in its own way," explains co-first author Hartland Jackson.

Refining breast cancer classification by multiplexed imaging
35 protein biomarkers create an unprecedented view of a tumor's cellular landscape and the surrounding tissue. (Image: Bernd Bodenmiller / UZH) Credit: Bernd Bodenmiller / UZH

Potential impact on breast cancer precision medicine

This finding has the potential to change clinical practice. The new subgroups of breast cancer patients vary in their molecular profiles. Bernd Bodenmiller and his research team are now working on finding out which drugs are best able to combat cells with a specific molecular profile. "By improving our ability to describe cellular features and categories as well as our ability to precisely identify patients that have high or low risk breast , we're opening up new possibilities for precision medicine," says Bodenmiller.

The study is published in the journal Nature.


Explore further

Precise decoding of breast cancer cells creates new option for treatment

More information: Nature (2020). DOI: 10.1038/s41586-019-1876-x
Journal information: Nature

Citation: Refining breast cancer classification by multiplexed imaging (2020, January 20) retrieved 17 February 2020 from https://medicalxpress.com/news/2020-01-refining-breast-cancer-classification-multiplexed.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
57 shares

Feedback to editors

User comments